Table 2. Multivariate logistic regression analysis comparing primary to secondary AML.
| Parameter | Odd ratio | Confidence interval | P-value |
|---|---|---|---|
| Age (⩽60 vs >60) | 2.80 | 1.68–4.64 | <0.001 |
| Cytogenetic analysis (normal karyotype vs others) | 2.14 | 1.10–4.16 | 0.026 |
| Cytogenetic analysis (normal karyotype vs others) | 1.64 | 0.90–2.97 | 0.105 |
| Cytogenetic analysis (normal karyotype vs others) | 1.27 | 0.56–2.84 | 0.566 |
| WBC (⩽15 000 vs >15 000) | 0.50 | 0.30–0.85 | 0.011 |
| FLT3 | 0.17 | 0.05–0.57 | 0.004 |
| NPM1 | 0.47 | 0.21–1.04 | 0.062 |
| DNMT3A | 0.33 | 0.16–0.67 | 0.002 |
| EZH2 | 5.35 | 1.15–25.03 | 0.033 |
| BCOR | 7.40 | 2.01–27.32 | 0.003 |
| SF3B1 | 7.06 | 1.69–29.44 | 0.007 |
| ASXL1 | 3.77 | 1.44–9.91 | 0.007 |
Abbreviations: AML, acute myeloid leukemia; WBC, white blood cell count.